Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive MelanomaNienke van Rooij, Ton N. Schumacher, John B.A.G. Haanen et al.|Journal of Clinical Oncology|2013Cited by 799
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-upJoost H. van den Berg, John B.A.G. Haanen, Bianca Heemskerk et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 196
TIL therapy broadens the tumor-reactive CD8<sup>+</sup>T cell compartment in melanoma patientsPia Kvistborg, Ton N. Schumacher, Chengyi J. Shu et al.|OncoImmunology|2012Cited by 176
Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Nina Schumacher, Bianca Heemskerk et al.|European Journal of Immunology|2016Cited by 41
Human cancer regression antigensPia Kvistborg, Ton N. Schumacher, Marit M. van Buuren|Current Opinion in Immunology|2013Cited by 34